VEGFA and wet macular degeneration: Despite recent advances in the treatment of CNV for wet AMD with anti-vascular endothelial growth factor A (VEGF) agents [23], anti-VEGF treatments remain ineffective for some patients and a significant proportion of these patients still develop severe visual loss and progress to legal blindness over time [24].